India’s Active Pharmaceutical Ingredient (API) industry, currently valued at an estimated $15–16 billion, is expected to grow at a compound annual growth rate (CAGR) of 5–7% through FY27 and FY28, according to a recent study by CareEdge Ratings. The projected growth is underpinned by supportive government policies, a structural shift towards high-potency and complex APIs, […]